It is also important for clinicians to realise that the presence of IMNM autoantibodies alone is not specific for myositis and, based off current research, there would be little benefit to anti-HMGCR antibody screening in patients as a way of identifying high-risk individuals [21]. Here, HMGCR is linked to myositis disease.